glp 1 for autoimmune inflammation A Closer Look at the Dermatological Profile of GLP-1 Agonists Microdosing GLP-1 for autoimmune conditions:

Notably, cancer cells with weaker antioxidant capacity showed greater sensitivity to MG (115)

Excessive release of glutamate and its binding with NMDA, -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), or kainite (KA) receptors promotes excitotoxicity cell injury with a consequent activation of many molecular pathways, resulting in intracellular calcium (Ca 2+ ) overload 90,91 , reactive oxygen species (ROS) production, mPT, and cell swelling with brain edema 92

How are we thinking about the medium term

In fact, 70-80% of your immune system is located in your gut

There's so much potential and prices will be all the better for more competition.